Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, August 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Solid Phase Extraction Technology for Bioanalysis from Thermo Scientific
Tuesday, May 13, 2014
Designed to provide robust, reproducible extractions at low elution volumes.

EquipNet Celebrates 15 Successful Years in Business
Saturday, May 10, 2014
Company helps clients to generate a significant amount of previously unidentified funds from assets that have been sitting idle.

DataApex Releases Control Driver for Symbiosis™ Technology Components
Wednesday, May 07, 2014
Clarity chromatography software can newly control spark Symbiosis™ Technology Components.

Agilent Technologies Expands Availability of Chromosorb GC Packings
Tuesday, May 06, 2014
Full line of Chromosorb and century series now available.

Enhanced Chromatography Data System Software for Lab Productivity
Monday, May 05, 2014
Agilent’s New OpenLAB CDS Increases Data Security, Lab Productivity, Cost Savings.

Clarity Newly Supports Advion’s Line of expression Compact Mass Spectrometers
Monday, April 28, 2014
DataApex announced the release of a control driver for Advion’s expression compact mass spectrometers (CMS).

Rapid and Reliable Determination of Phenolic Compounds in Soil
Saturday, April 26, 2014
An efficient and simple HPLC method with ultraviolet detection to determine phenolic compounds.

New Programmable HPLC Column Chiller/Heater
Thursday, April 24, 2014
New EchoTherm™ Model CO50 is ideal for chiral and biomedical chromatography.

Shimadzu Scientific Instruments Introduces Noviplex Cards
Wednesday, April 23, 2014
Noviplex™ Next Generation Plasma Sample Collection tool for accelerated blood plasma collection and disease analysis.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 757
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv